SciELO - Scientific Electronic Library Online

 
vol.21 número1Metabolismo de los estrógenos endógenos y cáncer de mamaSerotipos, perfil plasmídico y antibiotipos de cepas de Shigella flexneri aisladas de niños menores de 5 años con diarrea sanguinolenta usuarios de los servicios de Salud Pública índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Médica del Uruguay

versión On-line ISSN 1688-0390

Resumen

ROLDAN, Gloria; SOSA, Alejandra  y  RODRIGUEZ, Robinson. Anticoagulación en pacientes portadores de tumores a nivel del sistema nervioso central. Rev. Méd. Urug. [online]. 2005, vol.21, n.1, pp.23-29. ISSN 1688-0390.

Summary Background: thromboembolic complications are seen in 15% of patients with cancer. Patients with primary or secundary tumors of the central nervous system add to usual risk factors for oncologic patients, specific factors for thromboembolic complications. Since associated-risk to anticoagulant administration in patients with central nervous system injuries is usually overvalued, it is not usually recommended as prophylactic criteria. On the other way, once tromboembolic complications are proved, a therapeutic dosage must be indicated. Objective: to assess risk/benefit of anticoagulant administration to patients with central nervous system tumors according to prophylactic and therapeutic criteria. Methods: a ten-years old specific bibliography was reviewed. Conclusions: low dosage of anticoagulant administration with warfarine based on risk-benefit assessment and paramedical follow up is indicated in ambulatory patients with encephalic tumors. Thromboembolic prophylaxis benefit in surgery with low molecular weight heparine overtake haemorragic risk better than neurosurgery. Patients with thromboembolic complications benefited from anticoagulant administration as far as dosage follow up ranged therapeutic average.

Palabras clave : NEOPLASMAS CEREBRALES; ANTICOAGULANTES [uso terapéutico]; TROMBOSIS [complicaciones].

        · resumen en Español | Francés     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons